Peregrine Pharmaceuticals | PPHM - Stock


Peregrine Pharmaceuticals reported $29.2M in Stock for its fiscal quarter ending in July of 2024.



Stock Change Date
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
MannKind USD 35.31M 8.34M Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novavax USD 11.54M 1.97M Dec/2025
Repligen USD 170.46M 10.14M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025